GENE POLYMORPHISMS AS PREDICTORS OF TREATMENT EFFICACY AND TOXICITY IN PATIENTS WITH INDOLENT NON‐HODGKIN LYMPHOMAS RECEIVING BENDAMUSTINE AND RITUXIMAB. (June 2017) - Cencini, E.; Sicuranza, A.; Fabbri, A.; Raspadori, D.; Bocchia, M.